Kanser Biyolojisi ve Farmakolojisi (YL) (Tezli)
Ders İçerikleri
1. Semester
| Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
| KBY5113 | Cancer Biology and Genetics | 3+0+ | 8 | Compulsory |
| Molecular and genetic mechanisms in cancer. | ||||
| Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
| KBY5117 | Scientific Research Techniques and Publication Ethics | 2+0+0 | 6 | Compulsory |
| Scientific Research Designs Hypothesising Keeping Scientific Records Presentation of Data Scientific Report Writing Academic Publishing and Indexing Publication Ethics | ||||
2. Semester
| Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
| KBY5104 | Cancer Pharmacology | 3+0+ | 8 | Compulsory |
| General pharmacology concepts; absorption, distribution, excretion and detoxification mechanisms; features of the autonomic nervous system, neurotransmitters, drugs used in some diseases and their mechanisms of action; Drugs used in cancer treatment, their mechanism of action and adverse effects | ||||
| Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
| KBY5171 | Seminar | 2+0+0 | 6 | Compulsory |
| Making a presentation on a thesis topic | ||||
3. Semester
| Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
| KBY5191 | Thesis Study 1 | 0+0+0 | 30 | Compulsory |
4. Semester
| Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
| KBY5192 | Thesis Study 2 | 0+0+0 | 30 | Compulsory |
Department/Programme Elective Courses
| Course Code | Course Name | (T+A+L) | ECTS |
| KBY5002 | Cancer Pharmacology and Drug Transporters | 3+0+0 | 8 |
| Course Code | Course Name | (T+A+L) | ECTS |
| KBY5003 | Molecular Biology Techniques | 3+0+0 | 8 |
| Course Code | Course Name | (T+A+L) | ECTS |
| KBY5004 | Metastasis and Clinical Importance | 3+0+0 | 8 |
| Course Code | Course Name | (T+A+L) | ECTS |
| KBY5005 | Cell Culture Techniques | 3+0+0 | 8 |
| Tissue and cell culture definitions, application areas, sterile working conditions, microscopic analysis, in vitro cytotoxicity and cell death analysis. | |||
| Course Code | Course Name | (T+A+L) | ECTS |
| KBY5006 | Biology and Detection of Cell Death | 3+0+0 | 8 |
| Course Code | Course Name | (T+A+L) | ECTS |
| KBY5007 | Oncogenes and Carcinogenesis | 3+0+0 | 8 |
| Course Code | Course Name | (T+A+L) | ECTS |
| KBY5009 | Molecular Toxicology | 3+0+0 | 8 |
| Cellular mechanisms of toxicology and toxicity determination methods | |||
| Course Code | Course Name | (T+A+L) | ECTS |
| KBY5010 | Cancer Stem Cell | 3+0+0 | 8 |
| Stem cell Biology, hallmarks of cancer, cancer stem cell hypothesis, hallmarks of cancer stem cells, signalling pathways, process of metastasis, drug resistance, clinical importance | |||
| Course Code | Course Name | (T+A+L) | ECTS |
| KBY5011 | Cancer Bioinformatics | 3+0+0 | 8 |
| The content of this course is the effective use of bioinformatics tools during cancer research and targeted drug design approaches. Another important content of the course is to convey basic information about the effective use of existing mathematical models during the experimental design phase and the interpretation of the results. The elements necessary for drug design will be emphasised with the multiple perspectives that will be gained to the students. | |||
| Course Code | Course Name | (T+A+L) | ECTS |
| KBY5012 | Tumor Heterogeneity and Drug Resistance | 3+0+0 | 8 |
| Molecular and genetic mechanisms of tumoral heterogeneity in cancer and cancer drug resistance that develops in parallel with it. | |||
| Course Code | Course Name | (T+A+L) | ECTS |
| KBY5013 | Current Advancements in Cancer Research | 3+0+0 | 8 |
| 1. novel drugs 2. microbiota 3. spheroids 4. organoids 5. in ovo method 6. new hallmarks 7. new cell death modalities 8. nobel-related developments | |||
| Course Code | Course Name | (T+A+L) | ECTS |
| KBY5014 | Cancer Cell Metabolism | 3+0+ | 8 |
| Changes in cellular metabolism in cancer | |||
| Course Code | Course Name | (T+A+L) | ECTS |
| KBY5015 | Anticancer Drug Discovery | 3+0+0 | 8 |